Carlyle Group (CG)
(Delayed Data from NSDQ)
$46.33 USD
+1.59 (3.55%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $46.35 +0.02 (0.04%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CG 46.33 +1.59(3.55%)
Will CG be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for CG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CG
Why Carlyle Group (CG) is a Top Dividend Stock for Your Portfolio
Discover (DFS) Q2 Earnings Beat on High Interest Income
CG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Baxter (BAX) Shares Rise 2.4% in July: Will It Go Higher?
Carlyle Group (CG) Eyes Buyout of Baxter's Kidney Care Unit
Company News for July 8, 2024
Other News for CG
Carlyle Credit Income Fund Schedules Third Quarter 2024 Financial Results and Investor Conference Call
Carlyle's $4B Purchase Of Baxter's Kidney Division Backed By Ares And HPS Financing
Carlyle lines up $3B credit facility for Baxter unit, Bloomberg reports
Artisan Mid Cap Value Fund Q2 2024 Commentary
Moderna appoints David Rubenstein to board of directors